Receptor-specific ligands, including epidermal growth factor (EGF), heparin-binding EGF and transforming growth factor-α bind extracellular domains of individual ErbB receptors, cause receptor homo- or heterodimerization, and activate downstream signaling (12); this cascade results in adenoma initiation and progression. Here, EGF is linked to adenoma.